The taurine market size is projected to be valued at US$ 415.0 million in 2023 and is expected to rise to US$ 815.4 million by 2033. The sales of taurine are expected to record a significant CAGR of 7.2% during the forecast period.
Various factors propelling the demand for taurine are
Taurine is an amino acid that is necessary for the body's protein synthesis. It is essential for the healthy development of infants as well as those at risk of various diseases.
Taurine is frequently added to milk for infants who are not yet old enough to produce it on their own. Similarly, people who are on life support and are tube-fed require adequate amounts of the amino acid.
Taurine has the potential to save the lives of several patients. Its supplements also aid in the treatment of congestive heart failure, liver disease, cystic fibrosis, and high blood pressure. It also helps with the treatment of alcoholism, autism, ADHD, epilepsy, vision issues, and diabetes.
The rising prevalence of taurine deficiency in dogs and cats is fueling the demand for new healthy pet foods. Celebrity endorsements for pet food products via mainstream media and e-commerce are creating value-grab opportunities for taurine producers.
Companies in the global taurine market are looking for revenue opportunities in a variety of applications, such as cosmetics, cleaning products, and flavors, among others.
Certified Reference Material (CRM) for food and medicinal grade taurine that meets ISO requirements is available from companies. Certified pharmaceutical secondary standards for quality control provide a practical and cost-effective alternative to pharmacopoeia primary standards for pharmaceutical laboratories and manufacturers.
| Attribute | Details |
|---|---|
| Taurine Market Estimated Size (2023) | US$ 415.0 million |
| Taurine Market CAGR (2023 to 2033) | 7.2% |
| Taurine Market Forecasted Size (2033) | US$ 815.4 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Scientists and epidemiologists have named taurine a wonder molecule due to its health and wellness benefits. Research conducted by epidemiologists in Okinawa, Japan, suggests that in the region where the consumption of taurine is more, people have experienced better health.
Taurine has numerous health benefits due to which it is called a wonder molecule, such as improving athletic performance by supporting muscles, prevention of vision loss caused by aging, the ringing of ears due to tinnitus, improving the function of the heart, and many more.
According to FMI's analysis, taurine sales increased at a CAGR of 4.7% between 2018 and 2022.
Novel end-use applications of taurine are being recognized by manufacturers as well as consumers. This has resulted in the development of certain products containing taurine as an ingredient, for instance, baby food, cosmetics, and personal care. These two end-use applications of taurine are newly identified and as awareness increases, demand is certain to increase in the global market.
Key manufacturers of taurine such as Qianjiang Yongan Pharmaceutical Co., Ltd. are planning to further expand production as well as storage capacity to fulfill the increasing demand. Several companies are also planning to find novel alternate ways of production of taurine in a more environment-friendly way to eliminate the extraction of taurine from animals. Manufacturers such as Songzhou Hu, and Vitaworks Ip, Llc have developed and patented several production processes of taurine. FMI expects the global taurine market to record a 7.2% CAGR through 2033.
Principal Consultant
Taurine is usually produced in individuals and its secretion decreases with age. A taurine deficiency can also occur as a side effect of diseases like diabetes, cancer, or coronary disease. Certain diets for instance vegan and vegetarian contain less or no taurine content which makes it even more difficult to inclusion of taurine in the diet. Moreover, its deficiency often leads to health disorders such as certain pathological changes and cardiomyopathy, renal dysfunction, developmental abnormalities, and severe damage to retinal neurons.
To eliminate this, taurine is frequently used as a food and feed additive. American Association of Feed Control Officials (AAFCO) and the National Research Council (NRC) suggest the inclusion of taurine in the diet of dogs and cats in a regulated quantity that is assigned by them. Considering this, the rising prevalence of taurine deficiency due to age or underlying ailments has been creating growth opportunities.
According to a study by Nestle Nutrition, neonatal are not able to intake taurine because the mother losses her ability to produce taurine during the lactation period. Taurine is an essential amino acid for a neonatal in preterm or underweight. It is a standard practice to add taurine in an intravenous solution for such neonatal.
Besides this, as parents want to offer maximum nutritional benefits to their children, manufacturers such as PurAmino, and The Honest Company Organic are producing infant formula with essential nutrients and taurine.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The dietary supplements segment is expected to grow rapidly over the forecast period, with a CAGR of 11.5% from 2023 to 2033. With an increase in supplement launches containing ingredients such as taurine and caffeine, market players are prospects to have more opportunities to innovate existing products with various energy-based ingredients. According to William Reed Ltd., around 80% of Americans use energy-based dietary supplements such as thiamine, riboflavin, and niacin. Furthermore, a shift in consumer lifestyle and increased awareness of health and wellness products are expected to drive the segment's growth in the near future.
In terms of grade, the food grade segment is expected to be a lucrative segment by 2033. Increasing use of taurine in food and beverages, particularly functional and energy drinks and beverages, rising demand for highly functional foods and beverages among sportsmen, athletes, and fitness enthusiasts, rising awareness of health and wellness, and rising consumption of taurine-rich foods such as eggs, meat, and seafood are the key factors driving growth in this segment. As more food companies seek additives that include more nutrients in their products, the demand for ginseng is expected to rise in the coming years.
This rate of growth is due to increased demand for pet food and taurine dietary supplements. In the year 2023, there is likely to be a significant increase in the consumption of dog supplements and dietary supplements in the United States. This shift in behavior was caused by an increase in pet adoption and consumer awareness of the importance of maintaining a healthy lifestyle and boosting immunity.
Continued emphasis on heart disease prevention is further likely to influence American consumers to adopt a healthier lifestyle.
| United States Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 829.5 million |
|---|---|
| United States Market Absolute Dollar Growth (US$ million/billion) | US$ 315.21 million |
| CAGR % 2017 to 2022 | 6.7% |
| CAGR % 2023 to End of Forecast (2033) | 6.9% |
The overall market outlook is supported by steady growth in Taurine market demand in Western European countries, as well as rising consumption expenditure in Central and Eastern European countries. The growing health awareness among the population about the various benefits of dietary supplements is proliferating market growth. Furthermore, due to their convenience in accessibility, online retailers play a vital role in the industry's growth.
| United Kindom Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 40 million |
|---|---|
| United Kingdom Market Absolute Dollar Growth (US$ million/billion) | US$ 17.20 million |
| CAGR % 2017 to 2022 | 5.6% |
| CAGR % 2023 to End of Forecast (2033) | 5.5% |
Rapid economic growth, combined with a rapid increase in individual consumption power, is driving the market growth. The Chinese government is putting into effect several initiatives to address the country's rising health crisis, ranging from a promise to raise the quality of healthcare to the promotion of fitness and a healthy lifestyle. Internet use and international commerce are two strategies for improving the health of Chinese individuals.
Another factor contributing to the increase in demand for health supplement goods is the economic expansion and rising personal income. A rising proportion of consumers now perceive health supplements as commonplace goods, rather than high-end items and extravagant gifts.
| China Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 302.7 million |
|---|---|
| China Market Absolute Dollar Growth (US$ million/billion) | US$ 124.11 million |
| CAGR % 2017 to 2022 | 7.8% |
| CAGR % 2023 to End of Forecast (2033) | 7.9% |
Healthy ingredients are in high demand in Germany. With an increased emphasis on healthy living, Germany is expected to remain a highly profitable market in Europe and around the world throughout the forecast period. According to The Commonwealth Fund, heart disease mortality in Germany is on the rise. Taurine manufacturers may tap appealing opportunities to capitalize on in Germany, as various government and private organizations actively spread awareness about the importance of maintaining a healthy lifestyle.
| Germany Market Size (US$million/billion) by End of Forecast Period (2033) | US$ 65.23 million |
|---|---|
| Germany Market Absolute Dollar Growth (US$ million/billion) | US$ 22.83 million |
| CAGR % 2017 to 2022 | 5.6% |
| CAGR % 2023 to End of Forecast (2033) | 5.5% |
Due to the existence of several businesses operating both internationally and regionally, the digestive enzymes market is fragmented in character. A few well-known, internationally operating as well as domestically based businesses are examined in the competitive landscape, including Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd., Qianjiang Yongan Pharmaceutical Co., Ltd., Taisho Pharmaceutical Holdings Co., Ltd., Avanscure LifeSciences Pvt. Ltd., Atlantic Chemicals Trading GmbH, The Honjo Chemical Corporation.
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.2% from 2023 to 2033 |
| Base Year of Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | By Grade, By End-use Application, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd.; Qianjiang Yongan Pharmaceutical Co., Ltd.; Taisho Pharmaceutical Holdings Co., Ltd.; Avanscure LifeSciences Pvt. Ltd.; Atlantic Chemicals Trading GmbH; The Honjo Chemical Corporation |
| Customization & Pricing | Available upon Request |
The global taurine market size is to reach US$ 815.4 million by 2033.
North America is projected to emerge as a lucrative taurine market.
The growth potential of the global market is 7.2% through 2033.
The high cost of adoption is likely to limit market growth.
The United States is likely to secure a significant CAGR of 6.9% in 2023
1. Executive Summary | Taurine Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Metric Tons) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Analysis By End Use Application, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Metric Tons) Analysis and Forecast By End Use Application, 2023 to 2033
5.3.1. Food
5.3.2. Beverages
5.3.3. Animal Feed
5.3.4. Pet Food
5.3.5. Pet Supplement
5.3.6. Dietary Supplement
5.3.7. Cosmetic & Personal Care Products
5.3.8. Agriculture
5.3.9. Pharmaceuticals
5.4. Y-o-Y Growth Trend Analysis By End Use Application, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By End Use Application, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Million) & Volume (Metric Tons) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. MEA
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Million) & Volume (Metric Tons) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By End Use Application
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By End Use Application
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Metric Tons) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By End Use Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End Use Application
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Metric Tons) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By End Use Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End Use Application
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Metric Tons) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By End Use Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End Use Application
10.4. Key Takeaways
11. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Metric Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Metric Tons) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By End Use Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End Use Application
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. Value (US$ Million) & Volume (Metric Tons)ed States
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By End Use Application
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By End Use Application
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By End Use Application
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By End Use Application
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By End Use Application
12.6. United kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By End Use Application
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By End Use Application
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By End Use Application
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By End Use Application
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By End Use Application
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By End Use Application
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By End Use Application
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By End Use Application
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By End Use Application
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By End Use Application
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By End Use Application
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By End Use Application
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By End Use Application
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By End Use Application
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By End Use Application
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. MTC Industries
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.1.5.2. Product Strategy
14.1.1.5.3. Channel Strategy
14.1.2. Stauber USA.
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.2.5.2. Product Strategy
14.1.2.5.3. Channel Strategy
14.1.3. Foodchem International Corporation
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.3.5.2. Product Strategy
14.1.3.5.3. Channel Strategy
14.1.4. The Honjo Chenmical Corporation
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.4.5.2. Product Strategy
14.1.4.5.3. Channel Strategy
14.1.5. Qianjiang Yongan Pharmaceutical Co. Ltd.
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.5.5.2. Product Strategy
14.1.5.5.3. Channel Strategy
14.1.6. New Zealand Pharmaceutical Ltd.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.6.5.2. Product Strategy
14.1.6.5.3. Channel Strategy
14.1.7. Ajinomoto Co. Inc.
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.7.5.2. Product Strategy
14.1.7.5.3. Channel Strategy
14.1.8. Kyowa Hakko Bio Co. Ltd.
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.8.5.2. Product Strategy
14.1.8.5.3. Channel Strategy
14.1.9. Jiangsu Yuanyang Chemical Co. Ltd.
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.9.5.2. Product Strategy
14.1.9.5.3. Channel Strategy
14.1.10. Funchi Pharmaceutical Co., Ltd.
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.10.5.2. Product Strategy
14.1.10.5.3. Channel Strategy
14.1.11. Penta Manufaturing Company
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.11.5.2. Product Strategy
14.1.11.5.3. Channel Strategy
14.1.12. Mitsui Chemicals, Inc.
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
14.1.12.5.2. Product Strategy
14.1.12.5.3. Channel Strategy
14.1.13. AuNutra Industries Inc.
14.1.13.1. Overview
14.1.13.2. Product Portfolio
14.1.13.3. Profitability by Market Segments
14.1.13.4. Sales Footprint
14.1.13.5. Strategy Overview
14.1.13.5.1. Marketing Strategy
14.1.13.5.2. Product Strategy
14.1.13.5.3. Channel Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Food and Beverage Insights
View Reports
Taurine Market
